Clinical outcomes of COVID-19 infection in congenital heart disease: A single-center experience in Indonesia
- PMID: 36386329
- PMCID: PMC9663915
- DOI: 10.3389/fcvm.2022.1022183
Clinical outcomes of COVID-19 infection in congenital heart disease: A single-center experience in Indonesia
Abstract
Background: Congenital heart disease (CHD) patients are thought to be vulnerable to COVID-19 complications. In this study, we would like to assess the outcomes and clinical characteristics in COVID-19 CHD patients.
Method: A single-center, observational study was conducted in National Cardiovascular Center Harapan Kita (NCCHK). This study included patients with CHD who were hospitalized for COVID-19. The extracted data were baseline characteristics, clinical findings, supportive examination findings, complications, outcomes, and length of stay of the patients. The data were then analyzed using SPSS 26.0 software.
Result: Twenty-six patients with CHD and COVID-19 infection were included in our study. There were 24 resolved cases and 2 deaths, four patients experienced complications such as renal insufficiency (1), sepsis (2), and multiorgan failure (1). The median length of stay was 13 days. The most common symptoms experienced by the patients were breathlessness (65.4%), cough (57.7%), and fever (42.3%).
Conclusion: We observed a relatively mild COVID-19 clinical course despite prior research showing that patients with cardiovascular comorbidities, such as CHD, have a higher case-fatality rate. This could be because of the smaller sample size, non-standardized diagnosis, severity, treatment, and age group.
Keywords: CHD (congenital heart disease); COVID-19; clinical outcome; comorbidities; congenital heart disease.
Copyright © 2022 Siagian, Oetama, Pohan, Mendel, Lelya, Sakti and Kurniawati.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Impact of congenital heart disease on outcomes among pediatric patients hospitalized for COVID-19 infection.BMC Pediatr. 2023 May 16;23(1):240. doi: 10.1186/s12887-023-04058-2. BMC Pediatr. 2023. PMID: 37194031 Free PMC article.
-
COVID-19 and Congenital Heart Disease: Results from a Nationwide Survey.J Clin Med. 2020 Jun 8;9(6):1774. doi: 10.3390/jcm9061774. J Clin Med. 2020. PMID: 32521643 Free PMC article.
-
Inter-atrial Septum Stenting in Congenital Heart Disease Patient: A Case Series in Indonesia.Cardiovasc Hematol Disord Drug Targets. 2024;24(3):163-171. doi: 10.2174/011871529X320825240925073605. Cardiovasc Hematol Disord Drug Targets. 2024. PMID: 39411958 Free PMC article.
-
Pulmonary Arterial Hypertension in Indonesia: Current Status and Local Application of International Guidelines.Glob Heart. 2021 Apr 20;16(1):23. doi: 10.5334/gh.944. Glob Heart. 2021. PMID: 34040936 Free PMC article. Review.
-
Association between advanced paternal age and congenital heart defects: a systematic review and meta-analysis.Hum Reprod. 2020 Sep 1;35(9):2113. doi: 10.1093/humrep/deaa105. Hum Reprod. 2020. PMID: 32730591
Cited by
-
Impact of congenital heart disease on outcomes among pediatric patients hospitalized for COVID-19 infection.BMC Pediatr. 2023 May 16;23(1):240. doi: 10.1186/s12887-023-04058-2. BMC Pediatr. 2023. PMID: 37194031 Free PMC article.
References
LinkOut - more resources
Full Text Sources